InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,304.91
(
0.09%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BiotechValues

Send PM Follow Ignore
Followers 355
Posts 9910
Boards Moderated 2
Alias Born 06/23/2007

BiotechValues

Re: Chimaera post# 86608

Wednesday, 03/11/2015 1:38:39 PM

Wednesday, March 11, 2015 1:38:39 PM

Post# of 97239
$ZGNX- seems like a no-brainer to me when deal is worth $100M more than the market cap of company and they have two new drugs in development. The market for the Dravat's syndrome drug is tiny, but Relday = huge future market opportunity (if approved).

IRP Disclosure

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up